Targeting ALK averts ribonuclease 1-induced immunosuppression and enhances antitumor immunity in hepatocellular carcinoma - Liu, Chunxiao; Zhou, Chenhao; Xia, Weiya; Zhou, Yifan; Qiu, Yufan; Weng, Jialei; Zhou, Qiang; Chen, Wanyong; Wang, Ying-Nai; Lee, Heng-Huan; Wang, Shao-Chun; Kuang, Ming; et al. (Nature communications, 2024)
Keywords: 13/109; 13/31; 13/51; 13/95; 631/67/1059; 631/67/580; 692/4028/67/1504/1610/4029; Antibodies; Cancer; Cancer immunotherapy; CD8 antigen; Cytotoxicity; Hepatocellular carcinoma; Humanities and Social Sciences; Immune checkpoint inhibitors; Immunity; Immunosuppression; Immunotherapy; Kinases; Liver cancer; Lymphocytes T; Lymphoma; Macrophages; Microenvironments; Monoclonal antibodies; multidisciplinary; PD-1 protein; Phenotypes; Polarization; Protein-tyrosine kinase; Proteins; Ribonuclease; Science; Science (multidisciplinary); Signal transduction; Tumor microenvironment; Tumors